Alan W. Dunton, MD
Head of Research, Development & Regulatory Affairs
Alan W. Dunton, MD joined Purdue Pharma in November 2015 as Senior Vice President of Research & Development (R&D). His responsibilities include spearheading the Company’s overall research strategy and early clinical development programs. Dr. Dunton serves as the Company’s lead scientist and oversees the Medical Research, Drug Safety, Clinical Pharmacology, Virtual Discovery, Project Management and Pharmaceutics & Analytics teams.
Dr. Dunton has devoted his 33-year career to the discovery and development of new prescription and over-the-counter (OTC) drug products. In 2006, he founded Danerius LLC, a biotechnology and pharmaceutical consulting business, which he led until joining Purdue Pharma. Prior to starting Danerius, Dr. Dunton held executive-level positions in the pharmaceutical and biotechnology industries, including President and Chief Executive Officer of Panacos Pharmaceuticals, and Metaphore Pharmaceuticals. He was also the President and Managing Director of the Janssen Research Foundation, the R&D arm of the pharmaceuticals division at Johnson & Johnson. During his career, he has been responsible for the approval of more than 20 prescription and OTC products.
Dr. Dunton received his medical doctorate from New York University School of Medicine, where he completed his residency in internal medicine. He was a Fellow in Clinical Pharmacology at the New York Hospital/Cornell University Medical Center. Dr. Dunton is also a diplomat of the American Board of Internal Medicine and currently licensed to practice medicine in New Jersey and New York. He received his Bachelor of Science degree in biochemistry, magna cum laude, from State University of NY at Buffalo. Dr. Dunton was awarded The Nellie Westerman Prize from the American Federation for Clinical Research for his research in medical ethics.